Reata Pharmaceuticals Inc

TD ASSET MANAGEMENT INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/9/2023

Shares

6,600

Value ($000)

673

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/9/2023	673	0.0%	6,600	6/30/2023
2023 Q1	5/10/2023	806	0.0%	8,868	3/31/2023
2022 Q4	2/7/2023	491	0.0%	12,920	12/31/2022
2022 Q3	11/7/2022	299	0.0%	11,936	9/30/2022
2022 Q2	8/4/2022	363	0.0%	11,936	6/30/2022
2022 Q1	5/10/2022	441	0.0%	13,450	3/31/2022
2021 Q4	2/10/2022	932	0.0%	35,360	12/31/2021
2021 Q3	11/9/2021	2,668	0.0%	26,518	9/30/2021
2021 Q2	8/11/2021	3,354	0.0%	26,765	6/30/2021
2021 Q1	5/14/2021	2,950	0.0%	29,588	3/31/2021
2020 Q4	2/16/2021	3,319	0.0%	26,848	12/31/2020
2020 Q3	11/10/2020	2,046	0.0%	20,997	9/30/2020
2020 Q2	8/13/2020	3,120	0.0%	19,997	6/30/2020
2020 Q1	5/15/2020	3,045	0.0%	21,097	3/31/2020
2019 Q4	2/11/2020	6,766	0.0%	33,097	12/31/2019